Table 3 Clinical characteristics of the samples
Modified ERAS, N = 36 | SC, N = 25 | P value | |
|---|---|---|---|
Mean ± SD age, years | 59.8 ± 8.5 | 59.9 ± 9.6 | 0.971 |
Gender, n (%) | 0.037 | ||
Male | 27 (75) | 24 (96) | |
Female | 9 (25) | 1 (4) | |
Pathological finding, n (%) | 0.300 | ||
Urothelial cell carcinoma | 32 (88.8) | 19 (76) | |
Squamous cell carcinoma | 3 (8.8) | 3 (12) | |
Adenocarcinoma | 1 (2.7) | 3 (12) | |
Staging, n (%) | 0.615 | ||
Organ-confine disease (≤ pT2, pN0) | 12 (37.5) | 5 (25) | |
Extravesical disease (≥ pT3 or ≥ pN1) | 18 (56.2) | 13 (65) | |
Metastatic disease | 2 (6.2) | 2 (10) | |
Comorbidity, n (%) | |||
Cardiovascular disease | 9 (25) | 6 (24) | 0.929 |
Diabetes mellitus | 1 (2.7) | 2 (8) | 0.562 |
Renal insufficiency | 1 (2.7) | 9 (36) | 0.383 |
Anemia | 17 (47.2) | 6 (24) | 0.066 |
Hypoalbuminemia | 12 (33.3) | 6 (24) | 0.432 |
Body Mass index, n (%) | 0.061 | ||
Underweight | 20 (55.5) | 21 (84) | |
Norm weight | 15 (41.6) | 4 (16) | |
Overweight | 1 (2.7) | 0 | |
ASA score, n (%) | 0.549 | ||
2 | 27 (75) | 17 (68) | |
3 | 9 (25) | 8 (32) | |
Operative procedure, n (%) | 0.500 | ||
Open surgery | 17 (47.2) | 14 (56) | |
Laparoscopy | 19 (52.7) | 11 (44) | |
Urinary diversion, n (%) | 0.232 | ||
Ileal conduit | 16 (44.4) | 15 (60) | |
Transureterocutaneostomy | 20 (55.5) | 10 (40) |